Locus Cell Co., Ltd. is a Taiwanese contract development and manufacturing organisation (CDMO) specialising in regenerative medicine, particularly cell and gene therapies. The company provides end-to-end services, including process development, clinical and commercial manufacturing, and regulatory support, to accelerate the journey from discovery to commercialisation of advanced therapy medicinal products (ATMPs).

Headquartered in New Taipei City, Locus Cell operates the Zhubei Smart GMP Facility in the Hsinchu Biomedical Science Park. This facility is designed to meet both FDA and GMP standards and is among the few in Asia capable of both clinical and commercial production.

Key Products and Services

Contract Development and Manufacturing: Offering comprehensive services from process development to commercial manufacturing for cell and gene therapies.

Regulatory Support: Assisting clients with regulatory submissions and compliance, ensuring adherence to international standards.

Advanced Therapy Medicinal Products (ATMPs): Specialising in the development and manufacturing of ATMPs, including CAR-T therapies.

With a strong foundation in regenerative medicine and a commitment to quality and compliance, Locus Cell Co., Ltd. is well-positioned to support the global expansion of cell and gene therapies. The company’s strategic partnerships and state-of-the-art facilities underscore its role as a key player in the international pharmaceutical supply chain.